Lack of Cyp1b1 promotes the proliferative and migratory phenotype of perivascular supporting cells

Laboratory Investigation

Volumn 93, Issue 6, 2013, Pages 646-662

  Palenski, Tammy L ^a   Sorenson, Christine M ^a   Jefcoate, Colin R ^a   Sheibani, Nader ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

angiogenesis; cell migration; extracellular matrix proteins; integrins; NF KappaB; oxidative stress; signal transduction

Indexed keywords

ACETYLCYSTEINE; CYTOCHROME P450 1B1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THROMBOSPONDIN 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; ARYL HYDROCARBON HYDROXYLASES; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR MATRIX PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXIDATIVE STRESS; PERICYTES; RETINAL VESSELS; THROMBOSPONDINS; TRANSCRIPTION FACTOR RELA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878528305     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.55     Document Type: Article

References (60)

1. Hellstrom M, Kalen M, Lindahl P, et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999;126:3047-3055.
2. Rolny C, Nilsson I, Magnusson P, et al. Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation. Blood 2006;108:1877-1886.
3. von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res 2006;312:623-629.
4. Hayden MR, Yang Y, Habibi J, et al. Pericytopathy: Oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes. Oxid Med Cell Longev 2010;3:290-303.
5. Fleming I. Vascular cytochrome p450 enzymes: physiology and pathophysiology. Trends Cardiovasc Med 2008;18:20-25.
6. Coon MJ. Cytochrome P450: nature's most versatile biological catalyst. Annu Rev Pharmacol Toxicol 2005;45:1-25.
7. Stoilov I, Rezaie T, Jansson I, et al. Expression of cytochrome P4501b1 (Cyp1b1) during early murine development. Mol Vis 2004;10:629-636.
8. Murray GI, Melvin WT, Greenlee WF, et al. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 2001;41:297-316.
9. Hakkola J, Pasanen M, Pelkonen O, et al. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 1997;18:391-397.
10. Choudhary D, Jansson I, Rezaul K, et al. Cyp1b1 protein in the mouse eye during development: an immunohistochemical study. Drug Metab Dispos 2007;35:987-994.
11. Bejjani BA, Xu L, Armstrong D, et al. Expression patterns of cytochrome P4501B1 (Cyp1b1) in FVB/N mouse eyes. Exp Eye Res 2002;75: 249-257.
12. Ikegwuonu FI, Christou M, Jefcoate CR. Regulation of cytochrome P4501B1 (CYP1B1) in mouse embryo fibroblast (C3H10T1/2) cells by protein kinase C (PKC). Biochem Pharmacol 1999;57:619-630.
13. Zhang L, Savas U, Alexander DL, et al. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression. J Biol Chem 1998;273:5174-5183.
14. Tang Y, Scheef EA, Wang S, et al. CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood 2009;113:744-754.
15. Sutter TR, Tang YM, Hayes CL, et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 1994;269:13092-13099.
16. Kerzee JK, Ramos KS. Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHLH/PAS transcription factor. Circ Res 2001;89:573-582.
17. Heidel SM, Czuprynski CJ, Jefcoate CR. Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-Dimethylbenz[a]anthracene. Mol Pharmacol 1998;54:1000-1006.
18. Eltom SE, Zhang L, Jefcoate CR. Regulation of cytochrome P-450 (CYP) 1B1 in mouse Hepa-1 variant cell lines: a possible role for aryl hydrocarbon receptor nuclear translocator (ARNT) as a suppressor of CYP1B1 gene expression. Mol Pharmacol 1999;55:594-604.
19. Eltom SE, Larsen MC, Jefcoate CR. Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor. Carcinogenesis 1998;19:1437-1444.
20. Conway DE, Sakurai Y, Weiss D, et al. Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress. Cardiovasc Res 2009;81:669-677.
21. Brake PB, Arai M, As-Sanie S, et al. Developmental expression and regulation of adrenocortical cytochrome P4501B1 in the rat. Endocrinology 1999;140:1672-1680.
22. Buters JT, Sakai S, Richter T, et al. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 1999;96:1977-1982.
23. Choudhary D, Jansson I, Stoilov I, et al. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 2004;32:840-847.
24. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997;6:641-647.
25. Bejjani BA, Lewis RA, Tomey KF, et al. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 1998;62:325-333.
26. Libby RT, Smith RS, Savinova OV, et al. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 2003;299:1578-1581.
27. Tang Y, Scheef EA, Gurel Z, et al. CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress. Am J Physiol Cell Physiol 2010;298:C665-C678.
28. Hirase T, Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiology - Heart Circulatory Physiol 2012;302:H499-H505.
29. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21:193-215.
30. DiMaio TA, Sheibani N. PECAM-1 isoform-specific functions in PECAM- 1-deficient brain microvascular endothelial cells. Microvasc Res 2008;75:188-201.
31. Zhao W, Parrish AR, Ramos KS. Constitutive and inducible expression of cytochrome P450IA1 and P450IB1 in human vascular endothelial and smooth muscle cells. In Vitro Cell Dev Biol Anim 1998;34:671-673.
32. Gibson P, Gill JH, Khan PA, et al. Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development. Mol Cancer Ther 2003;2:527-534.
33. Wang XQ, Lindberg FP, Frazier WA. Integrin-associated protein stimulates alpha2beta1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases. J Cell Biol 1999;147:389-400.
34. Scheef EA, Sorenson CM, Sheibani N. Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1. Am J Physiol Cell Physiol 2009;296:C724-C734.
35. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005;97:512-523.
36. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62.
37. Tabruyn SP, Griffioen AW. NF-kappaB: a new player in angiostatic therapy. Angiogenesis 2008;11:101-106.
38. Partridge J, Carlsen H, Enesa K, et al. Laminar shear stress acts as a switch to regulate divergent functions of NF-kappaB in endothelial cells. FASEB J. 2007;21:3553-3561.
39. Romeo G, Liu WH, Asnaghi V, et al. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002;51:2241-2248.
40. Xu C, Shen G, Chen C, et al. Suppression of NF-kappaB and NF-kappaBregulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 2005;24:4486-4495.
41. Bonello S, Zahringer C, BelAiba RS, et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 2007;27:755-761.
42. Donato AJ, Eskurza I, Silver AE, et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium- dependent dilation and upregulation of nuclear factorkappaB. Circ Res 2007;100:1659-1666.
43. Kowluru RA, Koppolu P, Chakrabarti S, et al. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 2003;37:1169-1180.
44. Nehmé A, Edelman J. Dexamethasone inhibits high glucose-, TNF-a-, and IL-1b-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. Invest Ophthalmol Vis Sci 2008;49:2030-2038.
45. Darland DC, Massingham LJ, Smith SR, et al. Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 2003;264:275-288.
46. Song S, Ewald AJ, Stallcup W, et al. PDGFRbeta perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005;7:870-879.
47. Shono T, Ono M, Izumi H, et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 1996;16:4231-4239.
48. Flintoff-Dye NL, Welser J, Rooney J, et al. Role for the alpha7beta1 integrin in vascular development and integrity. Dev Dyn 2005;234:11-21.
49. Welser JV, Lange N, Singer CA, et al. Loss of the alpha7 integrin promotes extracellular signal-regulated kinase activation and altered vascular remodeling. Circ Res 2007;101:672-681.
50. Garmy-Susini B, Jin H, Zhu Y, et al. Integrin alpha4beta1-VCAM-1- mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 2005;115:1542-1551.
51. Dai J, Peng L, Fan K, et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009;28:3412-3422.
52. Lund SA, Giachelli CM, Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009;3:311-322.
53. Speer MY, Chien YC, Quan M, et al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 2005;66:324-333.
54. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27:2302-2309.
55. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000;275:20197-20203.
56. Fruttiger M. Development of the retinal vasculature. Angiogenesis 2007;10:77-88.
57. Wang S, Wu Z, Sorenson CM, et al. Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev Dyn 2003;228:630-642.
58. Greenberg JI, Shields DJ, Barillas SG, et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008;456:809-813.
59. Bartoli M, Platt D, Lemtalsi T, et al. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 2003;17:1562-1564.
60. Chen Z, Han ZC. STAT3: a critical transcription activator in angiogenesis. Med Res Rev 2008;28:185-200.